ChemSpider 2D Image | Carbidopa monohydrate | C10H16N2O5

Carbidopa monohydrate

  • Molecular FormulaC10H16N2O5
  • Average mass244.244 Da
  • Monoisotopic mass244.105927 Da
  • ChemSpider ID34931

  • defined stereocentres - 1 of 1 defined stereocentres

More details:

Featured data source
The Merck Index Online

Validated by Experts, Validated by Users, Non-Validated, Removed by Users

Carbidopa monohydrate
(2S)-3-(3,4-Dihydroxyphenyl)-2-hydrazino-2-methylpropanoic acid hydrate (1:1) [ACD/IUPAC Name]
(2S)-3-(3,4-Dihydroxyphenyl)-2-hydrazino-2-methylpropansäurehydrat (1:1) [German] [ACD/IUPAC Name]
(2S)-3-(3,4-dihydroxyphenyl)-2-hydrazinyl-2-methylpropanoic acid hydrate (1:1)
(S)-3-(3,4-Dihydroxyphenyl)-2-hydrazino-2-methylpropionic acid monohydrate
38821-49-7 [RN]
Acide (2S)-3-(3,4-dihydroxyphényl)-2-hydrazino-2-méthylpropanoïque, hydrate (1:1) [French] [ACD/IUPAC Name]
Benzenepropanoic acid, α-hydrazinyl-3,4-dihydroxy-α-methyl-, (αS)-, hydrate (1:1) [ACD/Index Name]
Carbidopa [BAN] [INN] [JAN] [USAN] [Wiki]
Carbidopa (hydrate)
More...

Validated by Experts, Validated by Users, Non-Validated, Removed by Users

38821-49-7,28860-95-9 [DBID]
  • Miscellaneous

    • Chemical Class:

      The hydrate of 3-(3,4-dihydroxyphenyl)propanoic acid in which the hydrogens <locant>alpha</locant>- to the carboxyl group are substituted by hydrazinyl and methyl groups (<stereo>S</stereo>-configurat ion). Carbidopa is a dopa decarboxylase inhibitor, so prevents conversion of levodopa to dopamine. It has no antiparkinson activity by itself, but is used in the management of Parkinson's disease to r educe peripheral adverse effects of levodopa. ChEBI CHEBI:3395
      The hydrate of 3-(3,4-dihydroxyphenyl)propanoic acid in which the hydrogens alpha- to the carboxyl group are substituted by hydrazinyl and methyl groups (S-configurat; ion). Carbidopa is a dopa decarb oxylase inhibitor, so prevents conversion of levodopa to dopamine. It has no antiparkinson activity by itself, but is used in the management of Parkinson's disease to reduce peripheral adverse effects of levodopa. ChEBI https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:3395
      The hydrate of 3-(3,4-dihydroxyphenyl)propanoic acid in which the hydrogens alpha- to the carboxyl group are substituted by hydrazinyl and methyl groups (S-configuration). Carbidopa is a dopa decarbox ylase inhibitor, so prevents conversion of levodopa to dopamine. It has no antiparkinson activity by itself, but is used in the management of Parkinson's disease to reduce peripheral adverse effects o f levodopa. ChEBI CHEBI:3395

Predicted data is generated using the ACD/Labs Percepta Platform - PhysChem Module, version: 14.00

No predicted properties have been calculated for this compound.

Click to predict properties on the Chemicalize site


Advertisement